Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
15 Leser
Artikel bewerten:
(0)

Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme

LONDON, March 14, 2014 /PRNewswire/ --

On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down 0.63%. The Dow Jones Industrial Average closed the session at 16,351.25, down 0.41% and the S&P 500 ended the day at 1867.63, lower by 0.51%. The losses were broad based as nine out of ten sectors ended the session in negative. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include Horizon Pharma Inc. (NASDAQ:HZNP), Norfolk Southern Corporation. (NYSE:NSC), Delphi Automotive PLC (NYSE: DLPH), and Solazyme Inc. (NASDAQ:SZYM). Free research on these four companies can be accessed at:

http://investor-edge.com/register

Shares in Horizon Pharma Inc. finished the day at $13.33, down 1.84%, hitting a new 52-week high of $14.27 on Tuesday. The stock reported a trading volume of 2.59 million shares during the trading session compared with the three-month average volume of 1.79 million shares. Horizon Pharma Inc.'s shares gained 74.93% on YTD basis. Shares of the company have rallied 33.17% in the last one month and 101.66% in the previous three months. The S&P 500 Health Care Sector Index mapped a loss of 0.26% during the session while the same has advanced 9.92% in the previous three months. The stock is trading above both its 50-day and 200-day moving averages. The company's 50-day moving average of $9.92 is above the 200-day moving average of $5.21. RSI of the company was 78.23 at the end of the session. Sign up and read the free notes on HZNP at:

http://www.Investor-Edge.com/03122014/HZNP/report.pdf

On Tuesday, Norfolk Southern Corp.'s stock gained 1.40%, finishing the day at $95.75, after hitting a new 52-week high of $95.99. The stock recorded a trading volume of 2.88 million shares, compared with the three-month average volumes of 2.15 million shares. The company's shares traded at a PE ratio of 16.39 and were up 3.15% on YTD basis. Shares of Norfolk Southern Corp. have advanced 1.32% in the past three trading sessions and 8.73% in the previous three months. The stock also witnessed a gain of 2.84% in the last one month. The S&P 500 Industrials Sector Index mapped a loss of 0.68% during the session while it charted up by 5.11% during the previous three months. The stock is trading above its 50-day and 200-day moving averages. Norfolk Southern Corp.'s 50-day moving average of $91.69 is above the 200-day moving average of $82.35. Furthermore, the company's shares were trading at the Relative Strength Index (RSI) of 60.13. The complimentary notes on NSC can be downloaded as in PDF format at:

http://www.Investor-Edge.com/03122014/NSC/report.pdf

Delphi Automotive PLC's stock traded in the range of $66.87 and $67.92, hitting a new 52-week high of $67.92. The company's stock reported a gain of 1.36%, ending the day at $67.77. A total of 3.30 million shares were traded, which is above the three months average volume of 1.93 million. The company's shares have advanced 7.62% in the last one month and 17.55% in the previous three months. The company stocks traded at a PE ratio of 15.49 and were up 12.71% on YTD basis. The S&P 500 Consumer Discretionary Sector Index posted gains of 3.33% in the last one month and 3.65% in the previous three months. The company's stock is trading above both its 50-day and 200-day moving averages. Delphi Automotive PLC's 50-day moving average of $62.73 is above the 200-day moving average of $57.26. The stock is trading at RSI of 65.34. Register for free on Investor-Edge and access the latest research on DLPH at:

http://www.Investor-Edge.com/03122014/DLPH/report.pdf

On Tuesday, Solazyme Inc.'s rallied 6.82%, to close the day at $14.41, hitting a new 52-week high of $14.44. The stock recorded a trading volume of 2.28 million shares, compared with the three-month average volume of 0.97 million shares. Solazyme Inc.'s shares advanced 32.32% on YTD basis. Shares of the company have surged 11.75% in the past three trading sessions and 69.33% in the previous three months. The stock has witnessed a gain of 29.70% in the last one month. The S&P 500 Energy Sector Index mapped a loss of 1.17% during the session while the same has advanced 2.58% in the last one month. The stock is trading above its 50-day and 200-day moving averages. The company's 50-day moving average of $11.20 is above the 200-day moving average of $10.90. Furthermore, shares of the company were trading at the Relative Strength Index (RSI) of 69.88. The complete research on SZYM is available for free at:

http://www.Investor-Edge.com/03122014/SZYM/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

=============

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] Investor-edge.com.
  • For any urgent concerns or inquiries, please contact us at compliance [at] Investor-edge.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] Investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.